Home › Epidermolysis Bullosa › California
Epidermolysis Bullosa clinical trials in California
3 studies for Epidermolysis Bullosa are looking for participants at sites in California.
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
- Mission Dermatology, Rancho Santa Margarita
- Stanford University School of Medicine Dermatology Department, Redwood City
RecruitingPhase 3
28 Days – 12 Years · All sexes · Updated Sep 4, 2026 · NCT07482787A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
- Stanford University School of Medicine, Dermatology Department, Palo Alto
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Aug 13, 2026 · NCT07027345Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Stanford University, Redwood City
RecruitingPhase 1/2
Ages 6 and older · All sexes · Updated May 5, 2026 · NCT06834035From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.